Mallinckrodt Pharmaceuticals Donates Drug Deactivation Pouches to Enable Safe Disposal of Prescription Drugs in West Virginia
Mallinckrodt Pharmaceuticals | October 15, 2016
Mallinckrodt Pharmaceuticals (NYSE: MNK), a leading global specialty pharmaceutical company, today announced it will provide more than 60,000 drug deactivation pouches to families in West Virginia to encourage the safe and responsible disposal of leftover prescription pain medications.